🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

SELLAS Life Sciences Group, Inc.

SLS Healthcare
$11.54 +$0.19 (1.67%)
Market Cap: $2.33 B
Gurus Holding
4
Popularity Rank
#2628
% of Shares Held
0.32%
Net Activity (Q2 2026)
+$8.7 M

Guru Ownership Trend

Guru Analysis for SELLAS Life Sciences Group, Inc. (SLS)

SELLAS Life Sciences Group, Inc. (SLS), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $7.42 M.

Top institutional holders include Renaissance Technologies (RenTech) and Jefferies Group.

Institutional sentiment is currently Bullish. This is evidenced by a $8.7 M net inflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who opened a new position.

Key Holders

Recent Activity Breakdown (Q2 2026)

+$8.7 M
Total Buy Value
New Buys 3
Additions 1
-$0
Total Sell Value
Reductions 0
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
0
Net Buyers
4

FAQs for SELLAS Life Sciences Group, Inc. (SLS)

Major holders include Renaissance Technologies (RenTech) ($4.58 M), Jefferies Group ($2.96 M), Joel Greenblatt ($1.1 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 643,287 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $8.7 M, with 4 managers increasing positions and 0 managers reducing holdings.

No tracked managers reduced or fully exited their positions in SLS during the most recent reporting period.

Yes, 3 managers opened new positions in SLS, and 1 increased their existing holdings. The total reported buy value was $8.7 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.01% New Buy 310,364 $4.58 M Q2 2026
0.02% New Buy 200,459 $2.96 M Q2 2026
0.00% New Buy 74,344 $1.1 M Q2 2026
0.00% Add 7.7% 58,120 $857,851 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form